| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| Mainz Biomed N.V.. (11/29/24). "Press Release: Mainz Biomed Announces Stock Split". Berkeley, CA & Mainz. |
2024-11-29 |
| Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
| Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
| VarmX B.V.. (11/12/24). "Press Release: VarmX Announces Appointment of John Glasspool as CEO". Leiden. |
2024-11-12 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| Forbion Capital Partners. (10/15/24). "Press Release: Forbion Raises in Excess of €2 Billion for Two New Funds". Naarden. |
2024-10-15 |
| Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen. |
2024-10-10 |
| Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". |
2024-10-10 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen. |
2024-10-10 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
| Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
| LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
| Halix B.V.. (9/19/24). "Press Release: Halix Appoints Dr. Lutz Hilbrich as New Chief Executive Officer". Leiden. |
2024-09-19 |
| Noah Labs GmbH. (9/19/24). "Press Release: Noah Labs Receives €3 Million in Financing Round Led by Nina Capital". Berlin & Potsdam. |
2024-09-19 |
| Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. |
2024-09-18 |
| Qiagen N.V.. (9/18/24). "Press Release: Qiagen Expands QIAcuity Digital PCR Offering with over New 100 Assays via GeneGlobe Platform". Venlo. |
2024-09-18 |
| ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base". |
2024-09-17 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Qiagen N.V.. (9/12/24). "Press Release: Qiagen and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil’s National Screening Programs". Venlo & Rio de Janeiro. |
2024-09-12 |
| Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona. |
2024-09-12 |
| Inflammatix, Inc.. (9/12/24). "Press Release: Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis". Sunnyvale, CA. |
2024-09-12 |
| Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
| Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
| Forbion Capital Partners. (9/11/24). "Press Release: Forbion Leads $14m Series A in Solasta Bio to Advance Development and Commercialisation of First-in-class Sustainable Crop Protection Solutions". Naarden. |
2024-09-11 |
| Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
| Mainz Biomed N.V.. (9/4/24). "Press Release: Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert". Berkeley, CA & Mainz. |
2024-09-04 |
| Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo. |
2024-09-04 |
| Organon & Co.. (9/3/24). "Press Release: Organon Appoints Daniel Karp as Executive Vice President, Corporate Development". Jersey City, NJ. |
2024-09-03 |
| Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo. |
2024-09-03 |
| Gilde Healthcare Partners. (9/2/24). "Press Release: Gilde Healthcare Appoints Jan Willem Bakker as Head of Investor Relations". Utrecht. |
2024-09-02 |
| Qiagen N.V.. (8/28/24). "Press Release: Qiagen Expands QIAstat-Dx into Precision Medicine through Partnership for Companion Diagnostics in Chronic Diseases". Venlo. |
2024-08-28 |
| InflaRx N.V.. (8/27/24). "Press Release: InflaRx Announces Participation in September Investor Events". Jena. |
2024-08-27 |
| Caresyntax. (8/15/24). "Press Release: Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery". San Francisco, CA & Berlin. |
2024-08-15 |
| PL BioScience GmbH. (8/8/24). "Press Release: PL BioScience Closes € 7.8 million Series A Financing". Aachen. |
2024-08-08 |
| AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
| Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin. |
2024-08-07 |
| Immatics N.V.. (7/31/24). "Press Release: Immatics Appoints Alise Reicin to Board of Directors". Houston, TX & Tübingen. |
2024-07-31 |
| AIRNA Corporation. (7/31/24). "Press Release: AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic". Cambridge, MA & Tübingen. |
2024-07-31 |
| Confo Therapeutics N.V.. (7/26/24). "Press Release: Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development". Ghent. |
2024-07-26 |
| Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva. |
2024-07-22 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing. |
2024-07-16 |
| Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
| Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA. |
2024-07-16 |
| Pan Cancer T B.V.. (7/11/24). "Press Release: Pan Cancer T Secures EUR 4.25 Million in Seed Extension Round to Advance Next-generation T Cell Therapies". Rotterdam. |
2024-07-11 |
| Etherna N.V.. (7/10/24). "Press Release: Antonin (Tony) de Fougerolles Appointed as New Chair of Etherna". Niel. |
2024-07-10 |
| HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
| SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
| BioRN Cluster Management GmbH. (7/8/24). "Press Release: Advancing Personalised Medicine in Europe. BioRN Is Part of the Renowned EU Research Project PRECISEU". Heidelberg. |
2024-07-08 |
| Anacura. (7/4/24). "Press Release: Anacura Acquires OHMX.bio, Adding Multi-omics for Drug Discovery and Diagnostics to Its Services". Ghent. |
2024-07-04 |
| Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert. |
2024-07-03 |
| Beacon Therapeutics Holdings Ltd.. (7/3/24). "Press Release: Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies". London & Cambridge, MA. |
2024-07-03 |
| Forbion Capital Partners. (6/27/24). "Press Release: Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office". Naarden. |
2024-06-27 |
| NLC Ventures Netherlands B.V.. (6/24/24). "Press Release: NLC Health Ventures Launches New Early-stage Drug Delivery Company". |
2024-06-24 |
| Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. |
2024-06-20 |
| Centogene N.V.. (6/20/24). "Press Release: C-Path and Centogene MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development". Tucson, AZ, Cambridge, MA & Rostock. |
2024-06-20 |
| iOnctura B.V.. (6/20/24). "Press Release: iOnctura Announces EUR80 Million Series B Financing to Progress Pipeline through Phase II Trials". Geneva & Amsterdam. |
2024-06-20 |
| Marea Therapeutics. (6/18/24). "Press Release: Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases". South San Francisco, CA. |
2024-06-18 |
| Forbion Capital Partners. (6/18/24). "Press Release: Forbion Co-leads $190 Million Financing of Marea Therapeutics". Naarden. |
2024-06-18 |
| Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin. |
2024-06-11 |
| BenevolentAI S.A.. (6/4/24). "Press Release: BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference". |
2024-06-04 |
| Annogen B.V.. (6/4/24). "Press Release: Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters". Amsterdam. |
2024-06-04 |
| NLC Ventures Netherlands B.V.. (6/3/24). "Press Release: Dutch Health Insurer VGZ Invests €6 Million in NLC Health Ventures". |
2024-06-03 |
| Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo. |
2024-06-03 |
| Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. |
2024-06-03 |
| Nyxoah S.A.. (5/31/24). "Press Release: Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares". Mont-Saint-Guibert. |
2024-05-31 |
| Adaptimmune Therapeutics plc. (5/30/24). "Press Release: Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future |
2024-05-30 |
| Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam. |
2024-05-29 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| TissUse GmbH. (5/28/24). "Press Release: Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment". Berlin. |
2024-05-28 |
| Meatable. (5/22/24). "Press Release: Meatable Appoints U.S.-based Meat industry Veteran Jeff Tripician as New CEO". Leiden. |
2024-05-22 |
| Captain T Cell GmbH. (5/22/24). "Press Release: Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million". Schönefeld/Berlin. |
2024-05-22 |
| Scion Instruments. (5/21/24). "Press Release: SCION Instruments Has a New CEO". |
2024-05-21 |
| Forbion Capital Partners. (5/21/24). "Press Release: Forbion Leads $65 Million Series A Financing of Progentos Therapeutics". Naarden. |
2024-05-21 |
| LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London. |
2024-05-21 |
| Pheon Therapeutics Ltd.. (5/21/24). "Press Release: Pheon Therapeutics Announces $120m Series B Financing to Fund Development of Its Differentiated ADC Pipeline". London. |
2024-05-21 |
| Biovance Capital Partners. (5/16/24). "Press Release: Biovance Capital Is the First Ever Investment in a Portuguese Life Sciences VC Fund by the EIF". |
2024-05-16 |
| Hephaistos-Pharma SAS. (5/16/24). "Press Release: Hephaistos Secures €10.3 M to Reach the Clinical Stage". France. |
2024-05-16 |
| Centogene N.V.. (5/15/24). "Press Release: Centogene Reports Full Year 2023 Financial Results and Recent Business Highlights". Cambridge, MA, Rostock & Berlin. |
2024-05-15 |
| Centogene N.V.. (5/15/24). "Press Release: Centogene Secures Approx. $20 Million to Strengthen Cash Position. Expanding Relationship With Lifera, a Biopharma Company Owned by the PIF". Cambridge, MA, Rostock & Berlin. |
2024-05-15 |
| Centogene N.V.. (5/14/24). "Press Release: Centogene and Evotec Discover Promising New Molecule to Treat Gaucher Disease". Cambridge, MA, Rostock & Berlin. |
2024-05-14 |
| iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies. |
2024-05-10 |
| Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. |
2024-05-09 |
| Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. |
2024-05-07 |
| Medios AG. (5/6/24). "Press Release: Medios AG – Constantijn van Rietschoten Appointed Executive Board Member for International Markets". Berlin. |
2024-05-06 |
| Karius, Inc.. (5/2/24). "Press Release: Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare". Redwood City, CA. |
2024-05-02 |
| Kurma Partners. (5/2/24). "Press Release: Kurma Partners Announces the Promotion of Hadrien Bouchez to the Position of Partner". Paris. |
2024-05-02 |
| Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. |
2024-04-29 |
| General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. |
2024-04-29 |
| Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. |
2024-04-29 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
